• Read more about Training Opportunity Available for Family and Caregivers of Adults Receiving Services Within Section 12, 19, and 96 Programs

The Office of Aging and Disability Services (OADS), in collaboration with the National Alliance on Mental Illness (NAMI) Maine is excited to announce a virtual training De-Escalation opportunity scheduled for Tuesday, December 10, 2024, from 3:00 PM – 5:00 PM.

This training is available for caregivers providing care to Section 12, 19, and 96 members. Caregivers can include personal support staff, attendants, home health aides, nurses or other natural and family supports.

• Read more about Reminder for Billing Attending Provider on UB-04 and 837I Claims, CR 110840

This is a reminder that the attending provider is required on all UB-04 and 837I claims. MaineCare denies UB-04 and 837I claims submitted without an enrolled attending provider.

The attending provider is the individual who has overall responsibility for the patient’s medical care and treatment reported in the claim/encounter. The attending provider requirement includes all claim submission methods (paper, HealthPAS Online Portal, or 837I).

• Read more about Taxonomy Code Requested on Claim Submissions – Portal Claims

The Office of MaineCare Services (OMS) is requesting that providers include the taxonomy code on all claims. The taxonomy code is necessary for the Centers for Medicaid and Medicare Services (CMS) to collect data for Transformed Medicaid Statistical Information System (T-MSIS) reporting. This data helps to inform states of their current standing in data quality as compared to other states and is crucial for research and policy on Medicaid and CHIP. The taxonomy is also used by  CMS to conduct program oversight, administration, and integrity.  

• Read more about Revalidate with MaineCare to Avoid Claim Denials

Per the Affordable Care Act (ACA), Section 6401, all providers need to revalidate with all states they are enrolled with.

Durable Medical Equipment (DME) providers are required to revalidate their information with MaineCare every three years. The current round of revalidation began in January 2022.  

• Read more about Rescheduled: Section 107, Psychiatric Residential Treatment Facilities (PRTFs): Revised Draft Rates Public Review and Comment Forum

The PRTF public review and comment forum has been rescheduled to December 17, 2024.  

MEETING DATE & TIME:  

Tuesday, December 17, 2024, 11:30AM – 1:00PM  

ZOOM Information: 

 https://mainestate.zoom.us/j/89397750850

Meeting ID: 893 9775 0850

---

One tap mobile +13092053325, 89397750850# US

---

Dial by your location +1 309 205 3325 US

• Read more about MaineCare Cost-of-Living Adjustments and Service Provider Tax (SPT) Repeal Update

Cost-of-Living Adjustments (COLA) 

Due to current projected budget limitations, the Department will only be applying COLAs on January 1, 2025, that are required by federal law. Other COLA adjustments will be reliant on additional appropriations by the legislature. 

SPT 

• Read more about DHHS By the Numbers

• Read more about Maine’s Children & Youth with Special Health Care Needs Webinar Learning Series: Childhood Lead Poisoning and Prevention

The Maine CDC Children and Youth with Special Health Care Needs is hosting Dr. Maggie Bordeaux of the Maine CDC Lead Program and invite you to join an insightful webinar on the effects of lead on children; children who are at risk for lead exposure, and ways to prevent lead exposure.

At the end of this presentation, participants will be able to:

• Read more about Update to the Biosimilar Preferred Drug List (PDL)

Effective January 1, 2025, the Department will add preferred and non-preferred drugs to the Biosimilar PDL, listed below.

Preferred drugs:  

• Q5108 – Fulphila, pegfilgrastim-jmdb 

Non-preferred drugs:  

• Read more about Attention Pharmacy Providers Under Title 5

Pharmacy providers whose pharmacy license is under a Title 5 review may use your Title 5 notice to extend your enrollment with MaineCare in MIHMS by six months, and for every six months thereafter, until the Title 5 review is resolved.